Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2025-12-26 @ 2:01 AM
Study NCT ID:
NCT04828005
Status:
COMPLETED
Last Update Posted:
2025-07-14
First Post:
2021-03-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pharmacodynamic Evaluation of Intranasal Nalmefene
Sponsor:
Opiant Pharmaceuticals Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-30
First Submit QC Date:
None
Study First Post Date:
2021-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-19
Results First Submit QC Date:
None
Results First Post Date:
2025-07-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-24
Last Update Post Date:
2025-07-14
Last Update Post Date Type:
ACTUAL